References
- Abbasi S, Azimi C, Othman F (2009). Risk factors for breast cancer in Iranian women: a case control study. Inter J Cancer Res, 5, 1-11. https://doi.org/10.3923/ijcr.2009.1.11
- Ahmad M (2003). Risk factors for breast cancer among women attending breast clinic in University Malaya Medical Centre Kuala Lumpur. NCD Malaysia, 2, 23-31.
- Clamp A, Danson S, Clemons M (2003). Hormonal and genetic risk factors for breast cancer. The Surgeon, 1, 23-31. https://doi.org/10.1016/S1479-666X(03)80005-7
- Coopman CP, Mueller SC (2006). Mini review: the SYK tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett, 241, 159-73. https://doi.org/10.1016/j.canlet.2005.11.004
- Coopman PJP, Do MTH, Barth M, et al (2000). The SYK tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature, 406, 742-7. https://doi.org/10.1038/35021086
- Harrison AP, Srinivasan K, Binu, VS, et al (2010). Risk factors for breast cancer among women attending a tertiary care hospital in southern India. Inter J Collaborative Res on Internal Medicine & Public Health, 2, 109-16.
- Hu YH, Nagata C, Shimizu H, et al (1997). Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat, 43, 65-72. https://doi.org/10.1023/A:1005745824388
- Hunter S, Sato N, Kim MK, et al (2000). Structural requirements of SYK kinase for Fcgamma receptor-mediated phagocytosis. Exp Hematol, 27, 875-84.
- Inayat U, Kayani MA, Rani F (2012). Sporadic mutation and expressional analysis of spleen tyrosine kinase gene in breast cancer. Pol J Pathol, 2, 106-11.
- Jemal A, Bray F, Melissa M (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kanwal S, Kayani MA, Faryal R (2012). Identification of novel SNPs in SYK gene of breast cancer patients: computational analysis of SNPs in the 50UTR. Mol Biol Rep, 39, 8345-51. https://doi.org/10.1007/s11033-012-1684-y
- Kruk J (2007). Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case-control study in the region of Western Pomerania (Poland). Asian Pac J Cancer Prev, 8, 513-24.
- Lakhani SR, Collins N, Sloane JP, et al (1995). Loss of heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol Mol Pathol, 48, 74-8. https://doi.org/10.1136/mp.48.2.M74
- Latour S, Zhang J, Siraganian RP, et al (1998). A unique insert in the linker domain of SYK is necessary for its function in immunoreceptor signalling. EMBO J, 17, 2584-95. https://doi.org/10.1093/emboj/17.9.2584
- Liu BA, Jablonowski K, Raina M, et al (2006). The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol Cell, 22, 851-68. https://doi.org/10.1016/j.molcel.2006.06.001
- Mahjabeen I, Baig RM, Masood N, et al (2012). Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients. Pathol Oncol Res, 10, 9567.
- Mc Pherson K, Stell CM, Dixon JM (2000). Breast cancerepidemiology, risk factors, and genetics. Br Med J, 321, 624-8. https://doi.org/10.1136/bmj.321.7261.624
- Minami Y, Ohuchi N, Fukao A (1997). Risk factors for breast cancer: a case-control study of screen-detected breast cancer Miyagi Prefecture, Japan. Breast Cancer Res Treat, 44, 225-33. https://doi.org/10.1023/A:1005883221114
- Naeem N, Nasir A, Aman Z, et al (2008). Frequency of HER-2/NEU receptor positivity and its association with other features of breast cancer. J Ayub Med Coll Abbottabad, 20, 23-6.
- Osborne C, Wilson P, Tripathy D (2004). Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist, 9, 361-77. https://doi.org/10.1634/theoncologist.9-4-361
- de Castro RO (2011). Regulation and Function of SYK Tyrosine Kinase in Mast Cell Signaling and Beyond. J Signal Transduction, 10, 507291.
- Toyama T, Iwase H, Yamashita H, et al (2002). Reduced expression of the SYK gene is correlated with poor prognosis in human breast cancer. Cancer, 189, 97-102.
- Wang L, Duke L, Zhang PS, et al (2003). Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res, 63, 4724-30.
- Yuan Y, Mendez R, Sahin A, et al (2001). Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res, 61, 5558-61.
Cited by
- Germline Variations of Apurinic/Apyrimidinic Endonuclease 1 (APEX1) Detected in Female Breast Cancer Patients vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7589
- Lack of Effects of Dietary Folate Intake on Risk of Breast Cancer: An Updated Meta-analysis of Prospective Studies vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2323
- The role of Syk signaling in antifungal innate immunity of human corneal epithelial cells vol.15, pp.1, 2015, https://doi.org/10.1186/s12886-015-0041-z
- Effects of Serum Triglycerides on Prostate Cancer and Breast Cancer Risk: A Meta-Analysis of Prospective Studies vol.68, pp.7, 2016, https://doi.org/10.1080/01635581.2016.1206582
- Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression vol.12, pp.3, 2016, https://doi.org/10.3892/ol.2016.4858